3.4
Arzneimittelresorption: Faktoren, die die GI-Resorption beeinflussen
Der Prozess der oralen Arzneimittelresorption kann von mehreren Faktoren beeinflusst werden. Schwach saure Arzneimittel neigen aufgrund ihres nichtion…
Die Resorption eines oral verabreichten Arzneimittels wird von verschiedenen Faktoren beeinflusst.
Schwach saure Arzneimittel werden eher aus dem Magen aufgenommen, wo sie überwiegend nichtionisiert sind.
Im Vergleich dazu kann die Resorption aus dem oberen Darm, der ionisierte Arzneimittel enthält, gering sein.
In Wirklichkeit erschwert die Magenschleimhaut die Diffusion. Die im Vergleich zum Darm kleinere Oberfläche reduziert die Absorptionsrate aus dem Magen weiter.
Die Darmzotten bieten eine größere Oberfläche, was in Verbindung mit einer höheren Durchblutung zu einer höheren Wirkstoffaufnahme führt.
Wenn sich die Nahrung im Magen befindet, können Medikamente schlecht resorbiert werden, da sie mit den Nahrungsbestandteilen Komplexe bilden.
Nahrung verzögert auch die Magenentleerung, dh die Bewegung von Medikamenten in den Dünndarm, wodurch die Darmabsorption verlangsamt wird.
Die schnelle Bewegung des Darminhalts bei Durchfall verlangsamt die Aufnahme des Arzneimittels weiter.
Außerdem pumpt das Darmepithel, das aus den P-Glykoprotein-Transportern besteht, die Medikamente oft zurück in das Darmlumen. Dadurch wird die Aufnahme von Arzneimitteln in das Blut reduziert.
View the full transcript and gain access to JoVE Core videos
Q1: Why is the small intestine a better site for drug absorption than the stomach?
The small intestine provides superior drug absorption due to its larger surface area created by intestinal villi, combined with higher blood flow. In contrast, the stomach has a smaller surface area and a thick mucous layer that hinders diffusion. These anatomical and physiological features make the intestine the primary site for drug absorption.
Q2: How does food in the stomach affect oral drug absorption?
Food interferes with drug absorption through two mechanisms: drugs form complexes with food constituents, reducing their bioavailability, and food delays gastric emptying, slowing the movement of drugs into the small intestine. This delayed transit further reduces the rate of intestinal absorption, ultimately decreasing overall drug absorption.
Q3: What role do P-glycoprotein transporters play in drug absorption?
P-glycoprotein transporters in the gut epithelium actively pump drugs back into the gut lumen, reducing their absorption into the bloodstream. This efflux mechanism acts as a barrier to drug absorption, limiting the amount of drug that enters systemic circulation from the gastrointestinal tract.
Q4: Why are weakly acidic drugs absorbed more readily from the stomach?
Weakly acidic drugs are predominantly nonionized in the stomach's acidic environment, allowing them to cross the stomach lining more easily through passive diffusion. In contrast, drugs in the upper intestine are often ionized, making them less able to penetrate the intestinal epithelium, resulting in lower absorption rates.
Q5: How does diarrhea impact drug absorption from the gastrointestinal tract?
Diarrhea accelerates the movement of gut contents through the gastrointestinal tract, reducing the time available for drug absorption. This rapid transit limits drug contact with the intestinal epithelium, resulting in decreased absorption and lower drug bioavailability in the bloodstream overall.
Q6: What is the relationship between surface area and drug absorption in the GI tract?
Surface area directly influences absorption rates: the intestine's larger surface area, enhanced by villi, supports greater drug absorption compared to the stomach's smaller surface. Combined with higher intestinal blood flow, this increased surface area facilitates more efficient drug uptake into systemic circulation.
Q7: How do ionization states of drugs affect their absorption at different GI sites?
Drug ionization state determines absorption efficiency at specific GI locations. Nonionized drugs, like weakly acidic drugs in the acidic stomach, cross membranes readily. Ionized drugs in the upper intestine have reduced membrane permeability, though the intestine's superior surface area and blood flow often compensate for lower ionization-based absorption.